Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
HCT
vs
S
S&P/ASX 300
HCT
Over the past 12 months, HCT has underperformed S&P/ASX 300, delivering a return of -50% compared to S&P/ASX 300's +3% growth.
Stocks Performance
HCT vs S&P/ASX 300
Performance Gap
HCT vs S&P/ASX 300
Create a free account · No card needed
Performance By Year
HCT vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Holista CollTech Ltd
Glance View
Holista CollTech is a health and wellness company that develops and sells collagen-based ingredients and finished products, along with natural hygiene and sanitising products. In simple terms, it works in two parts of the market: it supplies ingredients and also sells branded consumer products. Its offerings are aimed at people buying supplements and personal-care items, as well as businesses that want to use its ingredients in their own products. The company makes money mainly by selling products to distributors, retailers, and other business customers, and in some cases by supplying ingredients that are used in third-party products. That puts it somewhere between a specialty ingredient maker and a consumer health brand. Its role is less about mass-market grocery items and more about niche health formulas and functional products. What makes the business model different is its focus on collagen and natural wellness products rather than a broad catalogue of unrelated goods. This means the company depends on technical product development, formulation, and channel relationships with buyers who want specific health or hygiene products. For beginner investors, the key idea is that Holista CollTech is a niche health-products company that earns money by turning specialty formulations into sellable ingredients and branded items.
Create a free account · No card needed
